|
BRNS Barinthus Biotherapeutics PLC - ADR 1828185 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-10,580,000.00 |
| Balance Sheet |
|
Current Assets
|
$63,273,000.00 |
|
Assets
|
$81,893,000.00 |
|
Current Liabilities
|
$11,423,000.00 |
|
Liabilities
|
$24,759,000.00 |
|
Equity
|
$57,073,000.00 |
|
Shares Out
|
40848893.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-11,457,000.00 |
|
Investing Cash Flow
|
$116,000.00 |
| Market Analysis |
Market Cap
|
$24,917,824.73 |
|
Price
|
$0.61 |
|
BVPS
|
1.40 |
|
PB
|
0.44 |
|
EPS
|
-0.26 |
|
FCF
|
$-11,457,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BRNS documents filed with the SEC.
BRNS Filings
Clear
